As excessive or inadequate responses can be detrimental, immune responses to infection require appropriate regulation. Networks of signaling pathways establish versatility of immune responses. Drosophila melanogaster is a powerful model organism in dissecting conserved innate immune responses to infection. For example, the Toll pathway, which promotes activation of NF-κB transcription factors Dorsal/Dif, was first identified in Drosophila. Together with the IMD pathway, acting upstream of NF-κB transcription factor Relish, these pathways constitute a central immune signaling network. Inputs in these pathways contribute to specific and appropriate responses to microbial insults. Relish activity during infection is modulated by Ca 2+ -dependent serine/threonine phosphatase calcineurin, an important target of immunosuppressants in transplantation biology. Only one of three Drosophila calcineurin isoforms, CanA1, acts on Relish during infection. However, whether there is a role for calcineurin in Dorsal/ Dif immune signaling is not known. Here, we demonstrate involvement of specific calcineurin isoforms, Pp2B-14D/CanA-14F, in Toll-mediated immune signaling. These isoforms do not affect IMD signaling. In cell culture, pharmacological inhibition of calcineurin or RNA interference (RNAi) against homologous calcineurin isoforms Pp2B-14D/CanA-14F, but not against isoform CanA1 decreased Toll-dependent Dorsal/Dif activity. A Pp2B-14D gain-of-function transgene promoted Dorsal nuclear translocation and Dorsal/Dif activity. In vivo, Pp2B-14D/CanA-14F RNAi attenuated the Dorsal/Difdependent response to infection, without affecting the Relish-dependent response. Altogether, these data identify a novel input, calcineurin, in Toll immune signaling, and demonstrate involvement of specific calcineurin isoforms in Drosophila NF-κB signaling.
INTRODUCTION
While higher organisms have acquired adaptive immunity, most metazoans rely on the innate immune system to successfully fight off microbes. Depending on the type of immune insult, immune responses can be local or systemic, and control systems are in check to maintain these. Excessive or inadequate responses can be detrimental to the organism. Insight into the pathways regulating innate immunity is important for identifying how dysregulation causes disease, and could provide potential targets for therapeutic intervention.
Drosophila has been instrumental for the genetic dissection of immune defenses after infection to identify the involved pathways, which turned out to be evolutionarily conserved 1 . Two central pathways in Drosophila involved in the response to infection are the TNFR (Tumor Necrosis Factor Receptor)-related IMD (immunodeficiency) pathway and the Toll pathway, known as TLR (Toll-Like Receptor) in mammals. Signaling through IMD or Toll results in the activation of NF-κB transcription factors, which have a key role in mediating inflammatory gene expression. Important transcriptional targets are antimicrobial peptides (AMPs), which help to eliminate infections.
Recognition of PAMPs (pathogen-associated molecular patterns) on microbes, such as peptidoglycan (PGN), occurs through pattern recognition receptors (PRRs). While in mammals TLRs can serve as PRR and directly bind to PAMPs, Toll in Drosophila does not. Instead, Toll gets activated upon binding of a cytokine, spätzle. Spätzle gets cleaved downstream of a protease cascade, which gets activated upon binding of PAMPs (Lys-type PGNs on bacteria or b-glucans on fungi) to specific PRRs. Signaling downstream of Toll promotes activation of NF-κB transcription factors Dorsal and related transcription factor Dif. In contrast, PRRs that act upstream of IMD mediates responses to diaminopimalic (DAP)-type PGNs, mostly found on gram-negative bacteria. IMD signaling results in activation of NF-κB transcription factor Relish. AMPs downstream of Relish are more effective against gram-negative bacteria, whereas the Dorsal/Dif-specific AMPs help fight infections with gram-positive bacteria or fungi 1 . In addition to this humoral response to infection, the cellular response by hemocytes (blood cells) also plays a central defending role, by phagocytosing the microbes. The Toll pathway is also involved in this cellular response, as activation of this pathway promotes proliferation of hemocytes 2 .
Besides the canonical pathways that mediate recognition of microbes to activation of NF-κB transcription factors, there are other pathways that modulate their activity. For example, activity of the Ras/MAPK pathway negatively regulates IMD-Relish signaling 3 . Signaling by the small molecule nitric oxide (NO) can promote Relish activity independently of IMD 4 . Activation of Relish by NO occurs through the calcium-dependent serine/threonine phosphatase calcineurin 5 . This phosphatase constitutes a major target for immunosuppression and prevention of graft rejection in mammals. While the target of calcineurin involved in graft rejection, NFAT (Nuclear factor activated in T cells) is not present in Drosophila, calcineurin can also regulate the distantly related NF-κB in mammals 6, 7 .
Calcineurin acts as a heterodimer, consisting of a catalytic subunit A, and a regulatory subunit B. In Drosophila, there are 3 catalytic subunits: CanA1, and the related and functionally homologous Pp2B-14D and CanA-14F, which are next to each other on the chromosome and probably arose by gene duplication 8 . There are 2 B subunits, CanB and CanB2. CanB is mostly expressed in the brain, CanB2 is ubiquitously expressed (Flyatlas), and therefore CanB2 probably mediates signaling of the catalytic A subunits in immune tissues. Only CanA1 influences Relish activity in response to infection or to NO signaling, independently of IMD 4, 5 , indicating that calcineurin is not part of the canonical IMD-Relish signaling cascade. Differences in protein sequences may explain why CanA1 is sensitive to NO and Pp2B-14D/CanA-14F are not, but the structural base for this difference is not known. While treatment with a calcium-mobilizing drug can alter the mobility of Dorsal on SDS-PAGE, possibly via calcineurin 9 , a role for calcineurin in Dorsal/Dif-mediated immunity has never been explored (see Fig. 1A ).
Here, we examine a potential role for calcineurin in Dorsal/Dif-mediated immunity. We show that in cell culture, specific isoforms of the calcineurin catalytic subunit, Pp2B-14D and CanA-14F, can mediate nuclear translocation of GFP-tagged Dorsal (GFP-Dorsal). Co-immunnoprecipitation of Pp-2B-14D and GFP-Dorsal suggests that Dorsal may be a direct target for calcineurin. Toll-dependent activation of Dorsal/Dif was attenuated after pharmacologically inhibiting calcineurin or with RNAi against Pp2B-14D/CanA-14F. In vivo, flies expressing Pp2B-14D/CanA-14F RNAi constructs displayed a decrease in the Toll-dependent immune response and decreased viability after infection with gram-positive bacteria. Expression of active Pp2B-14D was sufficient to induce Dorsal/Dif-dependent expression of LacZ in hemocytes. Together, these data demonstrate involvement of specific calcineurin isoforms Dorsal/Dif-mediated immunity. Thus, specific calcineurin isoforms can modulate activity of either Relish or Dorsal/Dif in immunity, thus providing an additional means of regulation of immunity in Drosophila.
MATERIALS AND METHODS

Cells, flies, reagents, antibodies
Drosophila S2 cells were cultured in Schneider's medium (Gibco, San Diego, California, U.S.A.) supplemented with 10% heat-inactivated fetal calf serum, penicillin, and streptomycin. Cells expressing EGFR-Toll 10 were a generous gift from the Wasserman lab. Transient expression in S2 cells was done using Cellfectin (Invitrogen, Carlsbad, California, U.S.A.).
Daughterless-Gal4, hml-Gal4 and cg-GAL4 fly lines were obtained from the stock center (Bloomington, Indiana, U.S.A.). The srp-Gal4 line was a gift from B. Lemaitre; the Dorsal reporter D4/hsp70 11 was a gift from U. Banerjee (UCLA, Los Angeles, U.S.A.). RNAi lines for SERCA, CanA-14F and Pp2B-14D were obtained from VDRC (Vienna, Austria). Transgenic fly lines were made in the w1118 background, using Bestgene (Chino Hills, CA, U.S.A.).
Drosophila Pp2B-14D or DPp2B-14D, which is truncated at aa 470, cloned in frame with a C-terminal HA tag into pUAST or pAc5/V5HisB. A plasmid containing Dorsal was a gift from T. Yp, and was subsequently subcloned into pAc5/V5HisB containing GFP at the N-terminus using NotI and XbaI, thus generating GFP-Dorsal. The constructs for GFP-Relish 12 , DCanA1 5 GFP-VIVIT 13 and Dorsal-specific luciferase construct (353-Luciferase) 14 have been described previously. TK-renilla, was from Promega (WI, U.S.A.). All constructs were verified by sequencing.
GFP antibody was obtained from Life Technologies (Carlsbad, CA, U.S.A.); GFP-Trap from ChromoTek (Germany); HA monoclonal antibody (HA11) from BabCo (Richmond, CA, U.S.A.), Dorsal mAb from Developmental Studies Hybridoma Bank (Iowa city, IA, U.S.A.). FK506 (tacrolimus) was from USP Reference Standard (Rockville, MD). SNAP and thapsigargin were from Calbiochem (San Diego, CA, U.S.A.). Human EGF from Cellsciences (Canton, MA, U.S.A.). YM-5843 was from Sigma.
Primers:
Pp2B-14D/CanA-14F: 5'-GACTTCCTGCAGAACAACAACC-3'/5'CATCCGTTCGTTGACGGCATCC-3' and 5'-GGAGAAGACGATGATCGATA-3'/5'-GTGCGTGTAGAAGTCCGAGT-3'; CanA1: 5'-GGAGCGCATGGTCGATGA/5'-GGTTCTTCCGATACATGCGA-3' and 5'-ATCCTCGCACATCCACTCC/5'-TCAGGCACTGAAATAAATTGGC-3'; IM1: 5'-TGCCCAGTGCACTCAGTATC-3'/5'-GATCACATTTCCTGGATCGG-3'; Specificity of calcineurin signaling in Drosophila immunity IM2: 5'-AAATACTGCAATGTGCACGG /5'-ATGGTGCTTTGGATTTGAGG; Drosomycin: 5'-GTACTTGTTCGCCCTCTTCG-3'/5'-GATTTAGCATCCTTCGCACC-3'; Diptericin: 5'-ACCGCAGTACCCACTCAATC-3'/5'-ACTTTCCAGCTCGGTTCTGA-3'; Attacin: 5'-GCTTCGCAAAATAAACTGG-3'/5'-TCCCGTGAGATCCAAGGTAG-3' RP49: 5'-CCGCTTCAAGGGACAGTATC-3'/5'-GACAATCTCCTTGCGCTTCT-3', and also 21-mers of the full coding region of RP49. Dorsal mutagenesis primers: S3A mutant: 5'-ccgcagccgctgGcgccTGcAGCcaactacaaccacaac/ 5'gttgtggttgtagttgGCTgCAggcgCcagcggctgcgg-3'; S3D mutant: 5'-ccgcagccgctgGATccaGACGAcaactacaaccacaac-3'/ 5'-gttgtggttgtagttgTCGTCtggATCcagcggctgcgg-3'.
RNAi, nuclear translocation experiments and fluorescence
RNAi experiments were carried out as described in 15 , using a Promega T7 Ribomax kit to generate dsRNA. As control dsRNA, either LacZ or hMAZ dsRNA was used. Transient expression in S2 cells was carried out using Fugene transfection reagent (Promega) or PEI (polyethylenimine), using pAc5/V5HisB expression vector. Cells were transfected 3 days after adding dsRNA, and analyzed 40h later. Experimental procedures for preparing and analysis of the cells displaying nuclear GFP (GFP-Rel or GFP-Dl) have been described previously 5 . At least 300 cells were counted per sample for GFP localization. Images were taken on an inverted microscope (DM 1RB; Leica) equipped with a spinning disk confocal unit (CSU10; Yokagowa), 40× Plan Fluotar 0.7 NA objective (Leica), a camera (Orca AG; Hamamatsu Photonics), and Volocity 4 acquisition software (PerkinElmer). Samples were randomized prior to counting. Data represent the average of at least three independent experiments.
Immunoprecipitation and Western blot analysis
For pull down of GFP or GFP-tagged proteins, cells were lysed in a buffer containing 50mM HEPES pH 7.4, 0.5% NP40; 10% glycerol, 60mM KCl, 2mM CaCl 2 , supplemented with protease and phosphatase inhibitors. GFP pull down using GFP-Trap was performed according to manufacturer's protocol. Analysis by western blot and preparation of lysates for GFP-Dorsal mobility have been described previously 5 .
Luciferase assays
Cells expressing EGFR-Toll were transfected with appropriate plasmids. 6h after transfection 20-hydroxy ecdysone (1 mM) was added to the cells to sensitize them to immune induction 16 . EGF (0.2 ng/ml) was added overnight 30h after transfection. In case of pharmacological inhibition of calcineurin, inhibitors were added 30 min. prior to adding EGF. Luciferase activity was measured with the Dual Luciferase Assay System Kit (Promega, WI. U.S.A.), and samples were normalized with TK-Renilla. Data represent the average of at least three independent experiments. 
Infections
Analysis of hemocytes
Flies expressing active Pp2B-14D, a SERCA RNAi construct or control flies (w1118) were crossed to either hml-Gal4 or srp-Gal4. For the analysis of beta-galactosidase activity, hemocytes of third instar larvae were bled onto chilled coverslips coated with Concanavalin A, fixed with 4% formaldehyde and analyzed for beta-galactosidase activity as done previously 5 .
RESULTS
Calcineurin-dependent translocation of GFP-Relish and GFP-Dorsal
While calcineurin isoform CanA1 is a downstream target of nitric oxide (NO) in Relish signaling 5 , a possible involvement of NO or calcineurin in Toll-Dorsal/Dif (Dorsal-related Immune Factor) immune signaling has never been explored ( Fig.  1A ). There are indications for calcineurin involvement in Dorsal signaling: elevation of calcium results in a change in Dorsal phosphomobility 9 and Dorsal nuclear translocation 17 . Changes in mobility of Dorsal were prevented by pretreatment with a serine-threonine phosphatase inhibitor 18 . Furthermore, glutamate-dependent decrease of Dorsal levels in synaptic boutons at the neuromuscular junction was prevented by inhibition of calcineurin 19 . However, whether calcineurin is involved in Dorsal/Dif-dependent immunity and if there is a preference for a specific calcineurin isoform is unknown. A suitable way to identify players involved in Relish signaling is through examination of the nuclear translocation of GFP-tagged Relish (GFP-Rel) 5,20 , so we used the same assay for Dorsal signaling. To see whether NO, calcium, or calcineurin are involved in Dorsal signaling, nuclear translocation of GFP-Dorsal (GFP-Dl) was examined in Drosophila Schneider cells (S2 cells) and compared to that of GFP-Relish (GFP-Rel). As demonstrated before, a similar percentage of cells displaying nuclear GFP-Rel was observed after treatment with NO donor S-nitroso-N-acetylpenicillamine (SNAP) or after treatment with thapsigargin ( Fig. 1B  left) . Thapsigargin promotes a rise in cytoplasmic calcium by inhibiting transporter SERCA, responsible for the sequestration of Ca 2+ in the endoplasmic reticulum 21 .
In contrast, a much smaller percentage of cells displayed nuclear GFP-Dl ( Fig.  1B , right) after NO treatment, while thapsigargin-treated GFP-Dl cells showed a percentage similar to that of nuclear GFP-Rel ( Fig 1B, left) . To compare involvement of calcineurin in nuclear translocation of Dorsal and Relish, cells were treated with calcineurin inhibitor FK506 (or cyclosporin A, Suppl. Fig. 1B ) prior to treatment with SNAP or thapsigargin. As shown before 5 , FK506 treatment inhibited GFP-Rel translocation induced by both NO and thapsigargin. In cells expressing GFP-Dl, calcium-induced nuclear translocation was also largely abrogated by FK506. Altogether, these data suggest that the calcineurin isoform(s) activated upon increase of cytosolic calcium preferentially act on Dorsal.
Specific calcineurin isoforms involved in Dorsal translocation
Next, we tested which isoforms of the catalytic calcineurin subunit, CanA1, Pp2B-14D and/or CanA-14F, mediate nuclear translocation of Dorsal. The highly homologous Pp2B-14D and CanA-14F are next to each other on the chromosome and probably arose because of gene duplication. They were shown to be functionally redundant 22 . Therefore, we studied Pp2B-14D/CanA-14F together. The different isoforms differ at the N-or C-terminus, CanA1 differs from Pp2B-14D and CanA-14F throughout the protein. We examined a role for CanA1, or Pp2B-14D/CanA-14F in Dorsal signaling by RNAi, using 2 independent, non-overlapping dsRNAs to downregulate their expression. Homology between these isoforms and the regions of the dsRNAs targeting the different isoforms are shown in Suppl. Fig. 1A . For Pp2B-14D/CanA-14F we used dsRNAs that target both isoforms. We verified specific knockdown Specificity of calcineurin signaling in Drosophila immunity of calcineurin isoforms using RT-PCR, RNAi against Pp2B-14D/CanA-14F did not affect mRNA levels of CanA1 and vice versa ( Fig. 2A, top) .
We examined the effect of RNAi against the different calcineurin isoforms on thapsigargin-induced GFP-Dl translocation. Both dsRNAs targeting Pp2B-14D/ CanA-14F inhibited GFP-Dl translocation, whereas no effect on thapsigargininduced translocation was seen with CanA1 RNAi ( Fig. 2A, middle) . With CanA1 RNAi, NO-induced translocation of GFP-Rel was inhibited (not shown, 5 ), showing that CanA1 RNAi is sufficient to inhibit CanA1 activity. Quantification of these results is shown below ( Fig. 2A, bottom) .
A serine-rich region in Dorsal is homologous to that in NFAT, and these serines in NFAT are targets of calcineurin. Dephosphorylation of these serine residues promotes nuclear translocation of NFAT, concomitant with a mobility shift of NFAT on Western blot 23 . To see whether Dorsal mobility is affected upon calcineurin activation, and which calcineurin isoforms may be involved, we examined changes in GFP-Dl mobility on SDS-PAGE. Treatment with thapsigargin promoted a downward mobility shift, and this was inhibited by calcineurin inhibitor FK506 (Fig 2A, bottom) . When cells were treated with 2 different non-overlapping dsRNAs against Pp2B-14D/CanA-14F or CanA1, RNAi against Pp2B-14D/CanA-14F but not against CanA1 was able to interfere with the thapsigargin-induced GFP-Dorsal mobility shift ( Fig. 2A, bottom) . These data show that calcineurin isoforms Pp2B-14D/CanA-14F mediate thapsigargin-induced GFP-Dorsal translocation, possibly by dephosphorylating Dorsal.
To see whether a gain-of-function of calcineurin is sufficient to promote nuclear translocation of GFP-Dl, we expressed constitutively active DPp2B-14D (DPp2B), which lacks the autoinhibitory domain 24 . Indeed, expression of DPp2B-14D resulted in an increase in nuclear GFP-Dl (Fig. 2B , top). Quantification of these results is shown in Fig. 2B (bottom) . To see whether a gain-of-function of calcineurin can alter the mobility of Dorsal on Western blot, we expressed DPp2B. Indeed, upon expression of DPp2B, GFP-Dl was shifted downwards, possibly suggesting a decrease in phospho-content of Dorsal. (Fig. 2B, bottom 14 . Luciferase induced by EGF was largely inhibited upon addition of calcineurin inhibitor FK506 ( Fig. 2C ), suggesting that Toll activation promotes calcineurin activity involved in Dorsal/Dif signaling. Expression of active Pp2B-14D (DPp2B) but not of active CanA1 (DCanA1) was sufficient to induce luciferase, showing specificity of distinct calcineurin isoforms for inducing Dorsal/Dif activity. The luciferase induction by expression of active Pp2B-14D is lower than by EGF addition, possibly suggesting that additional components of the Toll pathway are required for optimal Dorsal/Dif transcriptional activity. We also tested whether calcineurin RNAi could interfere with Dorsal/Dif activity. We found that two independent dsRNAs targeting Pp2B-14D/CanA-14F attenuated luciferase induction, whereas no effect was found with two independent dsRNAs targeting CanA1. RNAi was not as efficient in EGFR-Toll cells as in regular S2 cells (not shown), possibly explaining the difference between pharmacological inhibition of calcineurin and RNAi against calcineurin. Activation of the Toll pathway results in phosphorylation and a concomitant increase in phosphomobility of Dorsal 18 . In EGFR-Toll cells, EGF treatment also resulted in an increase in phosphorylation of endogenous Dorsal (Fig. 2C, bottom) . However upon pharmacological inhibition of calcineurin, this phosphomobility was no longer seen with EGF. This may indicate that calcineurin activity is necessary for kinases in the Toll pathway to phosphorylate Dorsal.
To see whether calcineurin can act on the Toll pathway via direct interaction with Dorsal, we examined whether Dorsal can interact with Pp2B-14D. We also tested interactions of Pp2B-14D with GFP as a negative control and with GFP-VIVIT as a positive control. GFP-VIVIT is GFP fused to a peptide that contains the optimal binding site for calcineurin 13 . No interaction was found between GFP and HAtagged Pp2B-14D, whereas GFP-VIVIT bound HA-Pp2B-14D quite well (Fig. 2D ). GFP-Dorsal also co-precipitated Pp2B-14D, with a stoichiometry that appeared comparable to that of GFP-VIVIT and Pp2B-14D. This indicates that calcineurin may bind to and dephosphorylate Dorsal.
Dorsal contains putative consensus calcineurin serines in a serine-rich region (SRR), homologous to that of NFAT, which gets dephosphorylated by calcineurin to subsequently translocate to the nucleus 23 , presumably by exposing the NLS (nuclear localization signal). These serines in the SRR of Dorsal are different from the serines in the Rel homology region (S79, S103, S213, S312 and S317) that get phosphorylated by activation of the Toll pathway 25 . In GFP-Dorsal we mutated three serines in the SRR (S404, S413 and S414) to either alanine (phosphodefective) or aspartic acid (phosphomimetic), indicated in Fig. 2E , top. We examined the effect of these mutations on mobility of Dorsal, responsiveness to thapsigargin or Dorsaldependent luciferase activity. Mutations of the serines to alanine (S3A) resulted in a downward shift of Dorsal on Western blot, whereas the aspartic acid mutant (S3D) displayed an upward shift ( Fig. 2E, middle) . Treatment with thapsigargin resulted in Specificity of calcineurin signaling in Drosophila immunity a further downward shift of S3A, however, the downward shift with the S3D mutant was less than that of the wildtype (wt) GFP-Dorsal.
We also examined nuclear localization of these mutants: a significant fraction of S3A was present in the nucleus and this fraction was increased with thapsigargin treatment, but not as much as the control (Fig. 2E, bottom) . In contrast, the S3D mutant was cytoplasmic and thapsigargin treatment promoted nuclear translocation but the total fraction was lower than that of wildtype Dorsal. This indicates that phosphorylation of these serines are involved in mediating nuclear localization of Dorsal. However, since the response the S3A and S3D mutants to thapsigargin was attenuated but not inhibited, it indicates that additional serines are involved in mediating the response to calcium. This has been shown for NFAT as well 23 .
When we examined the effect of expressing GFP-Dorsal, its S3A or S3D mutant and examined their effect on Dorsal-dependent luciferase activity, we found that the increase in activity with GFP-Dorsal was further elevated in the S3A but not in the S3D mutant. This indicates that serines in the SRR of Dorsal are involved in mediating its transcriptional activity. These findings indicate that the serines in the SRR are target serines for calcineurin, and contribute to nuclear localization and activation of Dorsal.
Together, these data suggest that calcineurin can act on the Toll pathway by binding and subsequent dephosphorylation of Dorsal allowing nuclear translocation.
Specific calcineurin isoforms mediate Dorsal/Dif activity in vivo
Next, we investigated involvement of calcineurin isoforms Pp2B-14D/CanA-14F in Dorsal/Dif-mediated immune responses in vivo. We used Drosophila larvae, as Dorsal mediates immune responses in larvae but not in adults, where Dif alone is required 26 . This way, we could extend our S2 cell data, in which we used a Dorsal construct. We tested 2 independent Pp2B-14D/CanA-14F RNAi foldback constructs 27 , which specifically downregulated Pp2B-14D/CanA-14F mRNA without affecting CanA1 mRNA (Fig. 3A, top) . We infected larvae with gram-positive bacteria Micrococcus luteus (M. luteus) to induce the Toll pathway, using septic injury instead of natural infection (oral ingestion), as there was a high variability in oral bacterial intake in the larval population. We examined third instar larvae expressing GFP under control of the Dorsal/Dif-dependent drosomycin promoter (drs-GFP larvae). Following infection, GFP expression was induced, but this induction was lower when either Pp2B-14D/CanA-14F RNAi construct was expressed ( Fig 3A) . 
Specificity of calcineurin signaling in Drosophila immunity
To verify whether expression of endogenous Toll-dependent genes was also dependent on calcineurin, we examined drosomycin, IM1 and IM2 by RT-qPCR. Expression of all these genes was upregulated after infection (Fig. 3A, bottom) , and this was attenuated by downregulation of Pp2B-14D/CanA-14F expression. We also tested the whether Pp2B-14D/CanA-14F RNAi could affect the Relish-dependent response to infection with gram-negative bacteria Erwinia carotavora carotavora 15 (Ecc15). No significant changes were found on levels of the Relish-specific AMPs diptericin (Dipt) and attacin A (AttA) using RT-qPCR upon downregulation of Pp2B-14D/CanA-14F expression, arguing against a role for these isoforms in Relish signaling.
To examine the consequences of downregulating Pp2B-14D/CanA-14F expression on viability after infection we examined survival of these flies after septic injury with M. luteus. While no effect on viability was found with flies on control infected compared to uninfected flies, Pp2B-14D/CanA-14F RNAi decreased viability after infection but not in uninfected flies (Fig. 3B ). This demonstrates that Pp2B-14D/ CanA-14F are important mediators in the Toll pathway.
To test sufficiency for calcineurin in activating Dorsal/Dif in vivo, we generated flies containing an HA-tagged, active Pp2B-14D transgene (DPp2B-HA) and examined Drosophila hemocytes, in which Toll signaling is known to play a role 2 . Expression of this transgene was verified (Fig. 3C, top) . To visualize Dorsal/Dif activity, we examined induction of a beta-galactosidase transgene under control of a Dorsal/ Dif-specific promoter, D4/hsp70-LacZ 11 , containing binding sites specific for Dorsal/Dif 14 . While little beta-galactosidase activity was seen in control hemocytes (Fig. 3C, top) , a significant fraction of hemocytes expressing active Pp2B-14D displayed beta-galactosidase activity. Similar observations were made when other fly lines expressing this transgene were used, as well as by using other Gal4 lines with expression in hemocytes (not shown). This shows sufficiency of calcineurin in inducing Dorsal/Dif activity in vivo.
We also investigated whether elevations in cytoplasmic calcium could similarly induce Dorsal/Dif-dependent beta-galactosidase by expressing a SERCA RNAi foldback transgene. Inhibition of SERCA in S2 cells promoted calcineurin-dependent translocation of Dorsal (Fig. 1B) , mediated by isoforms Pp2B-14D/CanA-14F (Fig.  2) . Efficacy of this SERCA transgene was tested by RT-PCR in larvae ubiquitously expressing the SERCA RNAi construct (Fig. 3C, bottom) . We then expressed the SERCA RNAi transgene in the hemocytes and also observed Dorsal/Dif-dependent induction of LacZ. Similar results were found when a SERCA RNAi construct was used against a different region of SERCA (not shown). This suggests that elevation of calcium (and subsequent induction of calcineurin activity) can promote Dorsal/ Dif activity, although we cannot exclude calcium-independent effects of SERCA knockdown such as ER stress.
Thus, specific calcineurin isoforms are an important input for modulating the activity of either Relish or Dorsal/Dif without cross-activation between these NF-κB pathways. Specific inputs of calcineurin help to achieve appropriate and specific immune activation. 
DISCUSSION
We show that activity of the two distinct pathways of the NF-κB family in Drosophila, IMD-Relish and Toll-Dorsal/Dif, can be modulated by calcium-dependent serine/ threonine phosphatase, calcineurin. However, specificity of calcineurin activity in these pathways is achieved by distinct isoforms of the catalytic calcineurin subunit A interacting with each pathway. Calcineurin isoform CanA1 modulates activity of Relish, whereas the functionally homologous and related Pp2B-14D and CanA-14F mediate activity of Dorsal/Dif.
Previous work showed that activity of CanA1 modulates activity of Relish during infection 5 , and that CanA1 acts downstream of NO. When we set out to analyze whether NO could also be involved in Dorsal/Dif signaling we found that nuclear translocation of GFP-Dorsal by NO was much smaller compared to that of GFP-Relish. However, treatment with a drug that promotes elevation of intracellular calcium and subsequent activation of calcineurin resulted in much higher levels of GFP-Dorsal nuclear translocation. This suggests that calcineurin can mediate Dorsal signaling, but via a different isoform than CanA1. Subsequent RNAi experiments showed that the calcineurin isoforms responsible for GFP-Dorsal translocation were the functionally homologous and related Pp2B-14D and CanA-14F. We show here that RNAi targeting Pp2B-14D/CanA-14F downregulates the Dorsal/Dif-mediated response to gram-positive bacteria, whereas the Relish-dependent response to gram-negative bacteria was unaffected (Fig. 3A) . This decrease in response by Pp2B-14D/CanA-14F RNAi was accompanied with a decrease in survival (Fig. 3B ). This indicates that in vivo Pp2B-14D/CanA-14F are important in mediating Tolldependent signaling, and do not interact with IMD signaling. This is the first report implying calcineurin in Toll-mediated immune signaling, and demonstrating involvement of specific calcineurin isoforms in this pathway. Thus, calcineurin acts in both IMD and Toll signaling, and specificity of calcineurin in these pathways is acquired by specific isoforms acting on Dorsal/Dif or Relish. Involvement of calcineurin in Drosophila NF-κB immune signaling is summarized in a model (Fig. 4 ). Only CanA1 can act downstream of NO, and modulates Relish signaling in response to infection or to NO 5 . NO is generated during infection with gram-negative bacteria 4 . Pp2B-14D and CanA-14F are activated in response to calcium elevation, and can promote nuclear translocation and activation of Dorsal in cell culture downstream of Toll activation ( Fig. 2A-C) . In vivo, RNAi against Pp2B-14D/CanA-14F is sufficient to dampen the Dorsal/Dif-dependent response to infection with gram-positive bacteria, concomitant with a decrease in survival. These findings suggest that activation of Toll results in mobilization of calcium and subsequent activation of Pp2B-14D/CanA-14F.
Does calcineurin contribute to Toll signaling by directly acting on Dorsal? Pp2B-14D does co-precipitate with Dorsal. There is a putative calcineurin docking site (PxIxIT) 13 in Dorsal (aa 47-52: PYVKIT). However, mutation of this site did not abrogate association between Dorsal and Pp2B-14D (not shown). Recent analysis of docking sites on calcineurin substrate demonstrated that the calcineurin docking site is a bit more versatile 28 , so additional sites in Dorsal (such as aa 15-20; PAVDGQ) may serve as a calcineurin docking site. While we do not know whether the interaction between Dorsal and calcineurin is direct, it may allow calcineurin to dephosphorylate serine residues on Dorsal, which is the main residue of Dorsal that gets phosphorylated 25 . To examine whether Dorsal is a target for calcineurin, we mutated target phosphorylation sites for calcineurin on Dorsal in a serine-rich region (SRR), which is adjacent to the NLS (Fig. 2E) Pp2B-14D and CanA-14F. Activity of these calcineurin isoforms induces nuclear localization and contributes to activation of Dorsal. In the absence of Pp2B-14D/CanA-14F, responses to infection with gram-positive bacteria are attenuated and viability is decreased, demonstrating the importance for these isoforms in Dorsal/Dif activity. Since Pp2B-14D/CanA-14F are dependent on an increase in cytoplasmic calcium for their activation, we infer that activation of the Toll pathway is accompanied with calcium mobilization, possibly via the CRAC calcium channel (see suppl. Fig. 1B ).
localization of Dorsal and contribution to its activity ( Fig. 2E ). Previous work in Drosophila showed that Toll-dependent phosphorylation occurs in the N-terminal Rel Homology Domain, and that 6 serines in this domain are phosphorylated 25 . However, these are not calcineurin consensus sites. Our data and work on NFAT 29 suggest that calcineurin acts on residues in a serine-rich region. We also show that pharmacological inhibition of calcineurin inhibits Toll-dependent phosphorylation of Dorsal and Dorsal/Dif activity (Fig. 2C) Why NO only signals through CanA1 and not through Pp2B-14D/CanA-14F is not known. While the catalytic domains of these subunits are highly conserved (suppl. Fig. 1A) , the N-and C-termini of CanA1 are rich in serine and threonine, possibly allowing for posttranslational modification downstream of NO. Differences in calcineurin sequence may also account for the differences in substrate specificity. While the Pp2B-14D and CanA-14F are functionally redundant 22 , there may still be differences in their substrate specificity, as they differ in their N-and C-terminus (supp. Fig. 1A) . In mammals, the catalytic A subunits of calcineurin are also most variable in their N-and C-termini. A proline-rich region in the N-terminus of the catalytic calcineurin subunit CanA beta, is involved in recognition of NFAT 30 . The different isoforms appear to have different distinct targets in vivo, with CanA beta being the main regulator of NFAT activity (reviewed in 31 ). Isoform-specific inhibitors could be able to circumvent the significant side effects occurring with the current immunosuppressing drugs that target all calcineurin isoforms.
The calcium channel that mediates influx of calcium that promotes activation of NFAT is called CRAC (Ca 2+ release-activated Ca 2+ channel). Patients with mutations in this channel are severely immunocompromised. Interestingly, the identity of this channel, Orai1, was first identified in a Drosophila RNAi screen in S2 cells expressing human NFAT tested for mediators of nuclear translocation 32 , suggesting evolutionary conservation of calcium and calcineurin signaling. Dysregulation of calcium homeostasis, resulting in intracellular calcium elevation and subsequent calcineurin activation may result in aberrant Dorsal/Dif activation. This is supported by data showing that DPp2B-expressing larvae as well as SERCA RNAi-expressing larvae had increased levels of beta-galactosidase under control of a Dorsal/Dif-dependent promoter (Fig. 3B) . Moreover, the number of hemocytes was increased in these larvae (not shown). An increase in hemocyte numbers may also be mediated by Dorsal/Dif, since constitutive activation of the Toll pathway results in overproliferation of hemocytes 2 . Preliminary research suggests that the channel involved in calcium increase resulting in nuclear translocation of Dorsal as well as Dorsal/Dif-dependent transcription may indeed be Orai1. Pharmacological inhibition of CRAC, as well RNAi against Orai1, inhibited Dorsal/Dif-dependent translocation in response to thapsigargin (Suppl. Fig. 1B, left) . Moreover, pharmacological inhibition of this channel or Orai RNAi, attenuated Dorsal/Dif-dependent induction of luciferase downstream of Toll (Suppl. Fig. 1B, right ), suggesting putative involvement of this channel in Dif/Dorsal-dependent immunity.
Altogether, calcineurin is an important phosphatase involved in specific immune pathways in both flies and mammals. Specifically targeting the isoforms involved in these particular pathways as well as targeting phosphorylation sites of calcineurin substrates in these pathways may be a way to modulate immune activation. 
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A B (B) Putative involvement of CRAC in Toll signaling. Left: S2 cells were treated with dsRNA targeting LacZ or Orai for 3 days prior to transfection with GFP-Dl. 36h after transfection cells were either left untreated (con), treated with thapsigargin (1 μΜ, 1h; black bars) with or without pretreatment of CsA (2.5 nM) and analysed for nuclear localization of GFP. Data represent average of at least three independent experiments -/+ SEM. Right: EGFR-Toll-expressing S2 cells were treated with dsRNA targeting LacZ or Orai for 3 days prior to transfection with with a luciferase construct under control of a Dorsal/Dif-specific promoter. 30h after transfection cells were left untreated (con), treated with EGF overnight (EGF; 0.2 μg/ml, black bars), or pretreated with YM-5843 (low: 10 μM; high 20 μM) for 30 min. prior to overnight incubation with EGF and subsequent analysis of luciferase activity. Data represent the average of at least three independent experiments -/+ SEM.
(A) Alignment of the Drosophila calcineurin catalytic isoforms. Amino acids that are different are indicated in grey. Underlined amino acids: catalytic domain; in Italics: binding region to regulatory subunit CanB. Differences exist between the N-and C-terminus of all three isoforms; CanA1 is different in DNA and protein sequence throughout the protein.
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